MIRA INFORM REPORT

 

 

Report No. :

312279

Report Date :

02.06.2015

 

IDENTIFICATION DETAILS

 

Name :

MAKERS PHARMA PRIVATE LIMITED

 

 

Registered Office :

No 56/A2, 1st Floor, Pantheon Road, Egmore, Chennai – 600008, Tamilnadu

Tel. No.:

91-44-28582828 / 28582829

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

16.03.2005

 

 

Com. Reg. No.:

055683

 

 

Capital Investment / Paid-up Capital :

Rs.0.400 Million

 

 

CIN No.:

[Company Identification No.]

U51397TN2005PTC055683

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CHEM08313E

 

 

PAN No.:

[Permanent Account No.]

AAECM38334

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Distributor of Pharmaceutical Products.

 

 

No. of Employees :

15 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (44)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company engaged in the business as a distributors of pharmaceutical products having a satisfactory track.

 

The company is progressing well. General financial position of the company is normal and acceptable for business dealings. 

 

Trade relations are reported as fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Mahendra Kumar

Designation :

Director

Contact No.:

91-9840032568

Date :

26.05.2015

 

 

LOCATIONS

 

Registered Office :

No 56/A2, 1st Floor, Pantheon Road, Egmore, Chennai – 600008, Tamilnadu, India

Tel. No.:

91-44-28582828 / 28582829

Mobile No.:

91-9840032568 (Mr. Mahendra Kumar)

Fax No.:

91-44-28582830

E-Mail :

kmjainauditor@gmail.com

makerspharma123@yahoo.com

Area :

1650 Sq. ft.

Location :

Rented

 

 

DIRECTORS

 

AS ON 30.09.2013

 

Name :

Mahendra Kumar Milapchand Jain

Designation :

Director

Address :

Flat No.605, 6th Floor, B Block, Vimallachal Apartments, No.1088 P H Road, Vepery, Chennai - 600007, Tamilnadu, India

Date of Birth/Age :

15-07-1962

Qualification :

B.Com

Experience :

20 Years

Date of Appointment :

16.03.2005

PAN No.:

AANPM2662B

DIN No.:

01143798

 

 

Name :

Veena Jain

Designation :

Director

Address :

Flat No.605, 6th Floor, B Block, Vimallachal Apartments, No.1088 P H Road, Vepery, Chennai, 600007, Tamilnadu, India

Date of Birth/Age :

19-12-1964

Qualification :

B.Com

Experience :

15 Years

Date of Appointment :

16.03.2005

PAN No.:

AAMPV0657N

DIN No.:

02533268

 

 

KEY EXECUTIVES

 

Name :

Mr. Punit Haran

Designation :

Accountant

 


 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2013

 

Names of Shareholders

No. of Shares

%age holding

Mahendra Kumar

10000

25.00

Veena Jain

10000

25.00

Balsari Holdings Private Limited, India

5000

12.50

Surendra Plastics Private Limited, India

10000

25.00

Hotex Merchandise Private Limited, India

5000

12.50

Total

40000

100.00

 

 

AS ON 30.09.2013

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Bodies corporate

50.00

Directors or relatives of Directors

50.00

Total

100.00

 

BUSINESS DETAILS

 

Line of Business :

Distributor of Pharmaceutical Products.

 

 

Products :

Pharmaceutical Products

 

 

Brand Names :

--

 

 

Agencies Held :

  • Pfizer Limited
  • Astra Zeneca
  • MSD Pharmaceuticals
  • Roche

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Credit (60 days / 120 days)

 

 

Purchasing :

Credit (30 days)

 

PRODUCTION STATUS : NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Astra Zeneca Pharma India Limited

Name of the Person :

Mr. Elumulai

Contact No.:

91-9840839935

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Wholesalers, Retailers and End Users

 

Reference :

Medimak Pharma

Name of the Person :

Mr. Surendra Chopra

Contact No.:

91-9841139849

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

15 (Approximately)

 

 

Bankers :

Bank Name

Citi Bank N. A.

Branch

No.163, Anna Salai, Chennai - 600002, Tamilnadu, India

Person Name (With Designation)

Not Divulged

Contact Number

Not Divulged

Name of Account Holder

Makers Pharma Private Limited

Account Number

0711109005

Account Since (Date/Year of Account Opening)

2013

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

CC

Account Operation

Regular

Remarks (If any)

--

 

Auditors :

 

Name :

K Mukesh Kumar and Associates

Chartered Accountants

Address :

No.105 Govindappa Naicken Street, Suite No.18, 2nd Floor, Sowcarpet, Chennai – 600001, Tamilnadu, India

Tel. No.:

91-44-25360079 / 25394475

E-Mail :

kmjainauditor@yahoo.co.in

PAN No.:

AAKPM0347C

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Associates/Subsidiaries :

Not Available

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

500,000

Equity Shares

Rs.10/- each

Rs.5.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

40,000

Equity Shares

Rs.10/- each

Rs.0.400 Million

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

0.400

0.400

0.400

(b) Reserves & Surplus

29.592

23.533

17.655

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

29.992

23.933

18.055

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.120

0.092

0.092

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

0.120

0.092

0.092

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

83.280

67.281

53.752

(b) Trade payables

11.802

10.224

16.675

(c) Other current liabilities

6.001

4.649

7.510

(d) Short-term provisions

2.852

2.696

2.191

Total Current Liabilities (4)

103.935

84.850

80.128

 

 

 

 

TOTAL

134.047

108.875

98.275

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1.727

1.607

1.835

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

1.727

1.607

1.835

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

43.261

40.849

42.163

(c) Trade receivables

84.256

57.236

47.169

(d) Cash and cash equivalents

1.122

2.907

0.544

(e) Short-term loans and advances

3.681

6.276

6.564

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

132.320

107.268

96.440

 

 

 

 

TOTAL

134.047

108.875

98.275

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

448.710

403.330

351.717

 

 

Other Income

0.010

1.406

1.404

 

 

TOTAL                                     (A)

448.720

404.736

353.121

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Purchase of Stock-In-Trade

407.935

361.751

329.201

 

 

Changes in Inventories of Finished Goods Work-In-Progress and Stock-In-Trade

(2.412)

1.314

(13.328)

 

 

Employee Expenses

9.207

8.154

6.905

 

 

Others Expenses

14.886

16.837

16.376

 

 

TOTAL                                     (B)

429.616

388.056

339.154

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

19.104

16.680

13.967

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

9.634

7.681

6.541

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

9.470

8.999

7.426

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

0.402

0.424

0.519

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

9.068

8.575

6.907

 

 

 

 

 

Less

TAX                                                                  (H)

3.009

2.697

2.259

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

6.059

5.878

4.648

 

 

 

 

 

 

Earnings Per Share (Rs.)

15.15

14.69

11.62

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

NA

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin
(PAT / Sales)

(%)

1.35

1.46

1.32

 

 

 

 

 

Operating Profit Margin
(PBIDT/Sales)

(%)

4.26

4.14

3.97

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

6.76

7.88

7.03

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.30

0.36

0.38

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

2.78

2.81

2.98

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.27

1.26

1.20

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

0.400

0.400

0.400

Reserves & Surplus

17.655

23.533

29.592

Share Application money pending allotment

0.000

0.000

0.000

Net worth

18.055

23.933

29.992

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

53.752

67.281

83.280

Total borrowings

53.752

67.281

83.280

Debt/Equity ratio

2.977

2.811

2.777

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

351.717

403.330

448.710

 

 

14.675

11.251

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

351.717

403.330

448.710

Profit

4.648

5.878

6.059

 

1.32%

1.46%

1.35%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

Yes

5

Buyer visit details

Yes

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

Yes

17

Details of sister concerns

No

18

Major suppliers

Yes

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

Yes

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

---

33

Market information

---

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

------------------------------------------------------------------------------------------------------------------------------

 

COMPUTATION OF TOTAL INCOME

[RS. IN MILLION]

 

PARTICULARS

 

31.03.2014

Income from Business

 

9.068

Add: Expenses Disallowed u/s 40 (a)(ia)

--

 

Add : Disallowed u/s43B- (VAT Payable)

--

 

Add: Donation

1.025

 

Add: Income Tax

--

 

Add: Depreciation as per Income Tax Act 1961

0.402

1.427

Total

 

10.495

Less: Depreciation as per Income Tax Act 1961

0.336

0.336

 

 

10.159

Less : Deduction allowable u/s 80-G Donation

 

0.512

Taxable Income / (Loss)

 

9.647

 

 

 

Tax payable on

 

2.894

Add : Surcharge @10%

 

--

Total

 

2.894

Add: Education Cess @2%

0.058

 

Add: Secondary and Higher Educational Cess@1%

0.029

 

Add: Interest u/s 234A / B/ C

--

0.087

Total [A]

 

 2.981

Income u/s 115JB (MAT)

 

 

Book Profit

 

9.068

Tax on Above (15%)

 

1.360

Add : Surcharge @10%

 

--

 

 

1.360

Add: Education Cess @2%

0.027

 

Add: Secondary and Higher Educational Cess@1%

0.014

0.041

Total [B]

 

1.401

 

 

 

Tax Liability (A or B, whichever is Higher)

 

2.981

Less : Advance Tax / Tax Deducted at source

 

2.851

Total

 

0.130

Add : Interest u/s 234 B

--

 

Add : Interest u/s 234 C

--

--

 

 

 

Total Tax Payable / Refundable

 

0.130

Tax paid u/s 140 A

 

0.130

 

 

 

TAX PAYABLE ROUNDED OFF TO

 

0.130

 

 

 

 

 

------------------------------------------------------------------------------------------------------------------------------

 

NETWORTH STATEMENT

 

MR. MAHENDRA KUMAR JAIN

 

[RS. IN MILLION]

 

DETAILS OF ASSETS

 

IMMOVABLE PROPERTY

 

NATURE OF PROPERTY

 

LOCATION WITH FULL ADDRESS

EXTENT

MARKET VALUE

½ share in residential flat

Vimallachal Apartments, Poonamalee High Road, Vepery, Chennai – 600007, Tamilnadu, India

1500 Sq.ft.

15.000

Land at Balhotra

--

--

3.000

Shop

Ahmedabad

--

4.600

Shop

Ahmedabad

--

4.500

TOTAL [A]

27.100

 

                                                                    LIQUID ASSETS

 

NATURE OF ASSETS

 

PARTICULARS OF ASSETS

QUANTITY

MARKET VALUE

Investment in Business

--

--

3.665

Cash in Hand at Bank

--

--

0.723

Gold Jewellary and Coins

--

---

0.716

TOTAL [B]

5.104

 

Total Assets [A+B] : Rs.32.204 Million

 

DETAILS OF LIABILITIES

 

BORROWINGS

 

BORROWED FROM

PARTICULARS AND SECURITIES 

PURPOSE

AMOUNT OUTSTANDING

--

--

--

--

 

GUARANTOR FOR VARIOUS BORROWINGS BY FRIENDS / RELATIVES / COMPANY

 

GUARANTEED TO

FOR THE BORROWED BY

PURPOSE

GUARANTEED AMOUNT

--

--

--

--

 

Total Liabilities: Rs. 0.000 Million

 

 

 

TOTAL NETWORTH

 

Total Assets

Rs.32.204 Million

Less : Total Liabilities

Rs. 0.000 Million

Total

Rs.32.204 Million

 

------------------------------------------------------------------------------------------------------------------------------

 

NETWORTH STATEMENT

 

MRS. VEENA JAIN

 

[RS. IN MILLION]

 

DETAILS OF ASSETS

 

IMMOVABLE PROPERTY

 

NATURE OF PROPERTY

 

LOCATION WITH FULL ADDRESS

EXTENT

MARKET VALUE

½ share in residential flat

Vimallachal Apartments, Poonamalee High Road, Vepery, Chennai – 600007, Tamilnadu, India

2080 Sq.ft.

15.000

 

 

 

 

TOTAL [A]

15.000

 

                                                                    LIQUID ASSETS

 

NATURE OF ASSETS

 

PARTICULARS OF ASSETS

QUANTITY

MARKET VALUE

Investment in Business

--

--

5.400

Cash in Hand at Bank

--

--

1.157

Gold Jewellary and Coins

--

---

0.600

TOTAL [B]

7.157

 

Total Assets [A+B] : Rs.22.157 Million

 

DETAILS OF LIABILITIES

 

BORROWINGS

 

BORROWED FROM

PARTICULARS AND SECURITIES 

PURPOSE

AMOUNT OUTSTANDING

--

--

--

--

 

GUARANTOR FOR VARIOUS BORROWINGS BY FRIENDS / RELATIVES / COMPANY

 

GUARANTEED TO

FOR THE BORROWED BY

PURPOSE

GUARANTEED AMOUNT

--

--

--

--

 

Total Liabilities: Rs. 0.000 Million

 

 

TOTAL NETWORTH

 

Total Assets

Rs.22.157 Million

Less : Total Liabilities

Rs. 0.000 Million

Total

Rs.22.157 Million

 

 

------------------------------------------------------------------------------------------------------------------------------

 

COMPANY PROFILE

 

They take august pleasure in introducing ourselves as leading pharmaceutical distributors in Tamilnadu, having their base in Chennai, catering to all the leading Institutions and Hospitals throughout Tamilnadu.,

 

Makers Pharma Private Limited, incepted in the year 1994, almost completing 2 decades of excellent service in terms of supplies to not the only the Institutes and Hospitals .

 

They have pioneered their logistics in the field of Oncology, Anti Retrovirals, Virology, Nephrology, Gastroenterology and other leading specialities.

 

Some of their clients include Roche, MSD, Novartis, Wyeth, Fresenius, Pfizer, Astrazeneca, Boeringher, Allergan, Ferring, Abbott.,and also majority of the leading Indian Companies like Intas, Glenmark, Zydus, Serum Institute, Ranbaxy , Panacea Biotech,  Lupin, Cipla, Samarath, Eli lilly, Gengyme & Abbott Helathcare. etc.

 

Their Annual Turnover is approx Rs 500.000 Million per annum, with the state of the art office, with excellent cold chain storage facility and wonderful channels for supply chain management.

 

In addition to the above credentials, we have been supplying to the following leading hospitals:

 

  • Vijaya Hospitals             
  • Military Hospital
  • Cancer Institute               
  • T B Hospital
  • Christian Medical College and Hospital
  • Port Trust Hospital
  • Medplus Health Services                                     
  • CGHS, MIOT Hospital
  • Dr Kamakshi Memorial Hospital                
  • Railway Hospital
  • Chettinad Hospital                                   
  • Frontier Hospital
  • Madras Medical Mission Hospital                        
  • St. Isable Hospital
  • Pims Hospital, Pondicherry                               
  • Jipmer Hospital, Pondicherry Chennai
  • Meenakshi Hospital                         
  • Frontier Hospital
  • Global Hospital                                               
  • Sri Ramchandra Hospital
  • Billroth Group of Hospitals                            
  • Appaswamy Hospital
  • Life Line Hospital                                      
  • Sri KKCTH Hospital
  • Sundaram Medical Foundation                           
  • Dr Mehta Hospital Private Limited

 

------------------------------------------------------------------------------------------------------------------------------

 

TRADE REFERENCES

 

PARTICULARS

 

ADDRESS

Acure Pharma

121, NSC Bose Road, Chennai, Tamilnadu, India

Millions Pharma

Chennai, Tamilnadu, India

Medi Biotec

118, Ritherdon Road, Chennai, Tamilnadu, India

 

 

------------------------------------------------------------------------------------------------------------------------------

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10386151

05/11/2013 *

58,000,000.00

CITIBANK N. A.

NO.163,, ANNA SALAI,, CHENNAI, TAMIL NADU - 60000 
2, INDIA

B90623364

2

90289856

12/12/2005

5,000,000.00

CITIBANK

NO. 2; CLUBHOUSE ROAD, ANNA SALAI, CHENNAI, TAMIL 
NADU - 600002, INDIA

-

 

* Date of charge modification

 

NOTE :

The registered office of the company has been shifted from No.56/B1 Pantheon Road, Egmore, Chennai – 600008, Tamilnadu, India to the present address.


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs.63.61

UK Pound

1

Rs.97.27

Euro

1

Rs.69.63

 

 

INFORMATION DETAILS

 

Information Gathered by :

NYA

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

SNT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

0

--BUSINESS SCALE

1~10

5

--PROFITABILITY

1~10

5

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

----

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

44

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.